Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Serum 25-hydoxyvitamin D concentrations in relation to Hashimoto's thyroiditis: a systematic review, meta-analysis and meta-regression of observational studies.

Štefanić M, Tokić S.

Eur J Nutr. 2019 May 14. doi: 10.1007/s00394-019-01991-w. [Epub ahead of print] Review.

PMID:
31089869
2.

Genome-wide association analysis suggests novel loci for Hashimoto's thyroiditis.

Brčić L, Barić A, Gračan S, Brekalo M, Kaličanin D, Gunjača I, Torlak Lovrić V, Tokić S, Radman M, Škrabić V, Miljković A, Kolčić I, Štefanić M, Glavaš-Obrovac L, Lessel D, Polašek O, Zemunik T, Barbalić M, Punda A, Boraska Perica V.

J Endocrinol Invest. 2019 May;42(5):567-576. doi: 10.1007/s40618-018-0955-4. Epub 2018 Oct 3.

PMID:
30284222
3.

Expression of TIGIT and FCRL3 is Altered in T Cells from Patients with Distinct Patterns of Chronic Autoimmune Thyroiditis.

Štefanić M, Tokić S, Suver-Stević M, Glavaš-Obrovac L.

Exp Clin Endocrinol Diabetes. 2019 May;127(5):281-288. doi: 10.1055/a-0597-8948. Epub 2018 Jun 11.

PMID:
29890552
4.

miR-29a-3p/T-bet Regulatory Circuit Is Altered in T Cells of Patients With Hashimoto's Thyroiditis.

Tokić S, Štefanić M, Glavaš-Obrovac L, Kishore A, Navratilova Z, Petrek M.

Front Endocrinol (Lausanne). 2018 May 24;9:264. doi: 10.3389/fendo.2018.00264. eCollection 2018.

5.

Association of Low-Fat Dietary Pattern With Breast Cancer Overall Survival: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trial.

Chlebowski RT, Aragaki AK, Anderson GL, Simon MS, Manson JE, Neuhouser ML, Pan K, Stefanic ML, Rohan TE, Lane D, Qi L, Snetselaar L, Prentice RL.

JAMA Oncol. 2018 Oct 1;4(10):e181212. doi: 10.1001/jamaoncol.2018.1212. Epub 2018 Oct 11. Erratum in: JAMA Oncol. 2019 Apr 1;5(4):580.

6.

Measurable and Unmeasurable Features of Ultrasound Lymph Node Images in Detection of Malignant Infiltration.

Rotim T, Kristek B, Turk T, Kretić D, Perić M, Pušeljić I, Pandurović T, Štefanić M.

Acta Clin Croat. 2017 Sep;56(3):415-424. doi: 10.20471/acc.2017.56.03.08.

PMID:
29479907
7.

Association of increased eomesodermin, BCL6, and granzyme B expression with major clinical manifestations of Hashimoto's thyroiditis - an observational study.

Štefanić M, Tokić S, Suver Stević M, Glavaš-Obrovac L.

Immunol Invest. 2018 Apr;47(3):279-292. doi: 10.1080/08820139.2018.1423571. Epub 2018 Jan 10.

PMID:
29319368
8.

Estimated collective effective dose to the population from nuclear medicine diagnostic procedures in Croatia: A comparison of 2010 and 2015.

Kralik I, Štefanić M, Brkić H, Šarić G, Težak S, Grbac Ivanković S, Griotto N, Štimac D, Rubin O, Salha T, Ivanišević Z, Jurković S, Faj D.

PLoS One. 2017 Jun 29;12(6):e0180057. doi: 10.1371/journal.pone.0180057. eCollection 2017. Erratum in: PLoS One. 2017 Aug 3;12 (8):e0183010.

9.

Altered expression of CTLA-4, CD28, VDR, and CD45 mRNA in T cells of patients with Hashimoto's thyroiditis - a pilot study.

Tokić S, Štefanić M, Karner I, Glavaš-Obrovac L.

Endokrynol Pol. 2017;68(3):274-828. doi: 10.5603/EP.2017.0020.

10.

Apatite nanoparticles strongly improve red blood cell cryopreservation by mediating trehalose delivery via enhanced membrane permeation.

Stefanic M, Ward K, Tawfik H, Seemann R, Baulin V, Guo Y, Fleury JB, Drouet C.

Biomaterials. 2017 Sep;140:138-149. doi: 10.1016/j.biomaterials.2017.06.018. Epub 2017 Jun 18.

PMID:
28649014
11.

Novel method for fabrication of samples for cell testing of bioceramics in granular form.

Stefanic M, Zhang X.

J Appl Biomater Funct Mater. 2016 Nov 2;14(4):e449-e454. doi: 10.5301/jabfm.5000301.

PMID:
27373886
12.

The Expression of T Cell FOXP3 and T-Bet Is Upregulated in Severe but Not Euthyroid Hashimoto's Thyroiditis.

Tokić S, Štefanić M, Glavaš-Obrovac L, Jaman S, Novosadová E, Petrkova J, Navratilova Z, Suver Stević M, Petrek M.

Mediators Inflamm. 2016;2016:3687420. doi: 10.1155/2016/3687420. Epub 2016 Jul 5.

13.

Phase I study of nintedanib incorporating dynamic contrast-enhanced magnetic resonance imaging in patients with advanced solid tumors.

Lee CP, Taylor NJ, Attard G, Pacey S, Nathan PD, de Bono JS, Temple G, Bell S, Stefanic M, Stopfer P, Tang A, Koh DM, Collins DJ, d'Arcy J, Padhani AR, Leach MO, Judson IR, Rustin GJ.

Oncologist. 2015 Apr;20(4):368-9. doi: 10.1634/theoncologist.2014-0250. Epub 2015 Mar 20.

14.

Importance of interleukin 6 in pathogenesis of inflammatory bowel disease.

Takac B, Mihaljević S, Stefanić M, Glavas-Obrovac L, Kibel A, Samardzija M.

Coll Antropol. 2014 Jun;38(2):659-64.

PMID:
25145003
15.

Synthesis of bioactive β-TCP coatings with tailored physico-chemical properties on zirconia bioceramics.

Stefanic M, Milacic R, Drazic G, Škarabot M, Budič B, Krnel K, Kosmač T.

J Mater Sci Mater Med. 2014 Oct;25(10):2333-45. doi: 10.1007/s10856-014-5246-9. Epub 2014 Jun 12.

PMID:
24920371
16.

Prediction of the in vivo performance of enteric coated pellets in the fasted state under selected biorelevant dissolution conditions.

Stefanič M, Vrečer F, Rizmal P, Mrhar A, Bogataj M.

Eur J Pharm Sci. 2014 Oct 1;62:8-15. doi: 10.1016/j.ejps.2014.05.007. Epub 2014 May 15.

PMID:
24844699
17.

Polymorphisms of interleukin-23 receptor in patients with inflammatory bowel disease in a Croatian tertiary center.

Mihaljević S, Kibel A, Stefanić M, Glavas-Obrovac L, Takac B, Krznarić Z, Samardiija M, Pinotić L, Milas J, Segec I.

Coll Antropol. 2013 Dec;37(4):1171-7.

PMID:
24611330
18.
19.

Pilot study of variants of the IL-23R and STAT3 genes reveals no association with Hashimoto's thyroiditis in the Croatian population.

Stevic MS, Stefanic M, Tokic S, Glavas-Obrovac L, Mihaljevic S, Karner I.

Endocr Res. 2014;39(4):164-7. doi: 10.3109/07435800.2013.875038. Epub 2014 Jan 24.

PMID:
24460100
20.

Meta-analysis of vitamin D receptor polymorphisms and psoriasis risk.

Stefanic M, Rucevic I, Barisic-Drusko V.

Int J Dermatol. 2013 Jun;52(6):705-10. doi: 10.1111/j.1365-4632.2012.5813.x. Epub 2013 Mar 14. Review.

PMID:
23488577
21.

PAX8-PPARgamma oncogene in follicular thyroid tumors: RT-PCR and immunohistochemical analyses.

Pauzar B, Karner I, Glavas-Obrovac L, Stefanić M, Dmitrović B.

Coll Antropol. 2012 Nov;36 Suppl 2:79-82.

PMID:
23397760
22.

Non-functional parathyroid gland carcinoma, a rare malignant tumor of the head and neck.

Kotromanović Z, Birtić D, Vceva A, Medić D, Zubcić Z, Mihalj H, Kotromanović Z, Erić S, Dmitrović B, Stefanić M.

Coll Antropol. 2012 Nov;36 Suppl 2:23-5.

PMID:
23397750
23.

[Angiotensin-converting enyme insertion/deletion polymorphism and blood pressure regulation in type 2 diabetic patients].

Krajina-Andricević M, Zibar L, Glavas-Obrovac- L, Stefanić M, Avdicević M, Barbić J.

Acta Med Croatica. 2011 Oct;65 Suppl 3:14-9. Croatian.

PMID:
23120809
24.

The influence of gastric emptying kinetics on the drug release from enteric coated pellets in fasted state: an in vitro/in vivo correlation.

Stefanič M, Locatelli I, Vrečer F, Sever T, Mrhar A, Bogataj M.

Eur J Pharm Biopharm. 2012 Oct;82(2):376-82. doi: 10.1016/j.ejpb.2012.07.011. Epub 2012 Aug 1.

PMID:
22884655
25.

Polymorphisms of vitamin D receptor gene in the population of eastern Croatia with psoriasis vulgaris and diabetes mellitus.

Polić MV, Rucević I, Barisić-Drusko V, Miskulin M, Glavas-Obrovac L, Stefanić M, Karner I, Lipozencić J, Bacun T, Mihaljević I.

Coll Antropol. 2012 Jun;36(2):451-7.

PMID:
22856230
26.

Lack of association of vitamin D receptor gene 3'-haplotypes with psoriasis in Croatian patients.

Rucevic I, Stefanic M, Tokic S, Vuksic M, Glavas-Obrovac L, Barisic-Drusko V.

J Dermatol. 2012 Jan;39(1):58-62. doi: 10.1111/j.1346-8138.2011.01296.x. Epub 2011 Sep 27.

PMID:
21951018
27.

The influence of the different morphological changes on gastric mucosa on somatostatin cell number in antrum mucosa and serum somatostatin.

Mihaljević S, Katicić M, Krznarić Z, Dmitrović B, Karner I, Stefanić M, Pinotić L, Samardzija M, Bensić M.

Coll Antropol. 2011 Mar;35(1):5-8.

PMID:
21661347
28.

A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer.

Reck M, Kaiser R, Eschbach C, Stefanic M, Love J, Gatzemeier U, Stopfer P, von Pawel J.

Ann Oncol. 2011 Jun;22(6):1374-81. doi: 10.1093/annonc/mdq618. Epub 2011 Jan 6.

PMID:
21212157
29.

Phase I study of the angiogenesis inhibitor BIBF 1120 in patients with advanced solid tumors.

Mross K, Stefanic M, Gmehling D, Frost A, Baas F, Unger C, Strecker R, Henning J, Gaschler-Markefski B, Stopfer P, de Rossi L, Kaiser R.

Clin Cancer Res. 2010 Jan 1;16(1):311-9. doi: 10.1158/1078-0432.CCR-09-0694. Epub 2009 Dec 22.

30.

An open-label dose-escalation study of BIBF 1120 in patients with relapsed or refractory multiple myeloma.

Kropff M, Kienast J, Bisping G, Berdel WE, Gaschler-Markefski B, Stopfer P, Stefanic M, Munzert G.

Anticancer Res. 2009 Oct;29(10):4233-8.

31.

Vitamin D endocrine system and psoriasis vulgaris--review of the literature.

Rucević I, Barisić-Drusko V, Glavas-Obrovac L, Stefanić M.

Acta Dermatovenerol Croat. 2009;17(3):187-92. Review.

PMID:
19818218
32.

Comparison of 18F-FDG positron emission tomography and computed tomography in patients with colorectal carcinoma and lymphoma: our initial clinical experience.

Coha B, Radmilović K, Gardasanić J, Daković M, Stefanić M, Latić A, Mitrecić D.

Acta Clin Croat. 2009 Mar;48(1):35-9.

PMID:
19623870
33.

Bortezomib, dexamethasone, and fibroblast growth factor receptor 3-specific tyrosine kinase inhibitor in t(4;14) myeloma.

Bisping G, Wenning D, Kropff M, Gustavus D, Müller-Tidow C, Stelljes M, Munzert G, Hilberg F, Roth GJ, Stefanic M, Volpert S, Mesters RM, Berdel WE, Kienast J.

Clin Cancer Res. 2009 Jan 15;15(2):520-31. doi: 10.1158/1078-0432.CCR-08-1612.

34.

Association of vitamin D receptor gene 3'-variants with Hashimoto's thyroiditis in the Croatian population.

Stefanić M, Papić S, Suver M, Glavas-Obrovac L, Karner I.

Int J Immunogenet. 2008 Apr;35(2):125-31. doi: 10.1111/j.1744-313X.2008.00748.x. Epub 2008 Feb 11.

PMID:
18279374
35.

Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors.

Kulimova E, Oelmann E, Bisping G, Kienast J, Mesters RM, Schwäble J, Hilberg F, Roth GJ, Munzert G, Stefanic M, Steffen B, Brandts C, Müller-Tidow C, Kolkmeyer A, Büchner T, Serve H, Berdel WE.

Mol Cancer Ther. 2006 Dec;5(12):3105-12.

36.

Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups.

Bisping G, Kropff M, Wenning D, Dreyer B, Bessonov S, Hilberg F, Roth GJ, Munzert G, Stefanic M, Stelljes M, Scheffold C, Müller-Tidow C, Liebisch P, Lang N, Tchinda J, Serve HL, Mesters RM, Berdel WE, Kienast J.

Blood. 2006 Mar 1;107(5):2079-89. Epub 2005 Nov 8.

PMID:
16278310
37.

Association of vitamin D receptor gene polymorphism with susceptibility to Graves' disease in Eastern Croatian population: case-control study.

Stefanić M, Karner I, Glavas-Obrovac L, Papić S, Vrdoljak D, Levak G, Krstonosić B.

Croat Med J. 2005 Aug;46(4):639-46.

38.

Metabolic effects of novel N-1-sulfonylpyrimidine derivatives on human colon carcinoma cells.

Glavas-Obrovac L, Karner I, Stefanić M, Kasnar-Samprec J, Zinić B.

Farmaco. 2005 Jun-Jul;60(6-7):479-83.

PMID:
15913614
39.
40.

Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study.

Bunjes D, Buchmann I, Duncker C, Seitz U, Kotzerke J, Wiesneth M, Dohr D, Stefanic M, Buck A, Harsdorf SV, Glatting G, Grimminger W, Karakas T, Munzert G, Döhner H, Bergmann L, Reske SN.

Blood. 2001 Aug 1;98(3):565-72.

PMID:
11468151
41.

CD34+ selected cells in mismatched stem cell transplantation: a single centre experience of haploidentical peripheral blood stem cell transplantation.

Bunjes D, Duncker C, Wiesneth M, Stefanic M, Dohr D, Harsdorf S, Karakas T, Reske SN, Bergmann L.

Bone Marrow Transplant. 2000 May;25 Suppl 2:S9-11.

42.

Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome.

Duncker C, Dohr D, Harsdorf S, Duyster J, Stefanic M, Martini C, Treiber M, Hertenstein B, Novotny J, Arnold R, Heimpel H, Bergmann L, Bunjes D.

Bone Marrow Transplant. 2000 Jun;25(12):1263-8.

43.
44.

Treatment of steroid-resistant acute graft-vs-host disease after allogeneic marrow transplantation with anti-interleukin-2 receptor antibody (BT563).

Hertenstein B, Stefanic M, Sandherr M, Bunjes D, Mertens T, Arnold R.

Transplant Proc. 1994 Dec;26(6):3114-6. No abstract available.

PMID:
7998086
45.

Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant.

Hertenstein B, Stefanic M, Schmeiser T, Scholz M, Göller V, Clausen M, Bunjes D, Wiesneth M, Novotny J, Kochs M.

J Clin Oncol. 1994 May;12(5):998-1004.

PMID:
8164054
46.

[Leukocyte transfusion as therapy of recurrent CML after allogenic bone marrow transplantation].

Wiesneth M, Hertenstein B, Bunjes D, Novotny J, Stefanic M, Heinze B, Schreiner T, Kubanek B, Heimpel H, Arnold R.

Beitr Infusionsther Transfusionsmed. 1994;32:276-80. German.

PMID:
9480108
47.

Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia.

Hertenstein B, Kern WV, Schmeiser T, Stefanic M, Bunjes D, Wiesneth M, Novotny J, Heimpel H, Arnold R.

Ann Hematol. 1994 Jan;68(1):21-6.

PMID:
8110874
48.

Interferon-alpha and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation.

Hertenstein B, Wiesneth M, Novotny J, Bunjes D, Stefanic M, Heinze B, Hübner G, Heimpel H, Arnold R.

Transplantation. 1993 Nov;56(5):1114-8.

PMID:
8249110
49.

Receptors for tumor necrosis factor on neoplastic B cells from chronic lymphocytic leukemia are expressed in vitro but not in vivo.

Digel W, Schöniger W, Stefanic M, Janssen H, Buck C, Schmid M, Raghavachar A, Porzsolt F.

Blood. 1990 Oct 15;76(8):1607-13.

PMID:
2169926
50.

Tumor necrosis factor-alpha, but not lymphotoxin, stimulates growth of tumor cells in hairy cell leukemia.

Buck C, Digel W, Schöniger W, Stefanic M, Ragnavachar A, Heimpel H, Porzsolt F.

Leukemia. 1990 Jun;4(6):431-4.

PMID:
2162999

Supplemental Content

Loading ...
Support Center